Safety of ADU-1604 in Adults With Metastatic Melanoma
NCT03674502
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class
Stopped
Study terminated due to business realignment
Conditions
Metastatic Melanoma
Interventions
DRUG:
ADU-1604
Sponsor
Aduro Biotech, Inc.